TL;DR
This paper introduces XA4C, a novel method that uses explainable autoencoders to identify "Critical genes" – genes that significantly contribute to learned representations of gene expression data. Unlike traditional methods, XA4C provides a more nuanced understanding of gene function by revealing genes that capture complex interactions, offering new insights into disease mechanisms.
What Problem Does This Paper Address?
Understanding the complex interplay of genes in biological systems, particularly in diseases like cancer, is a major challenge. Traditional methods for identifying important genes, such as those that are differentially expressed (DiffEx) or highly connected in co-expression networks (Hub genes), often capture only marginal effects or simple correlations. While representation learning (RL) techniques, like autoencoders, can uncover complex, non-linear relationships in noisy data, the learned "latent variables" are notoriously difficult to interpret. This lack of interpretability hinders the ability to pinpoint specific genes for functional follow-up. The paper addresses this gap by developing a method that bridges the interpretability gap in RL, allowing for the identification of functionally relevant genes that might be missed by conventional approaches.
Methods
The core of XA4C is an eXplainable Autoencoder (XA4C). It combines two key components:
- Autoencoders (AEs): These are unsupervised neural networks used for representation learning. XA4C employs AEs to learn compressed, low-dimensional representations (latent variables) of gene expression data. The paper uses both whole-transcriptome AEs and pathway-specific AEs.
- Explainable Artificial Intelligence (XAI) - SHAP: To interpret the AE's learned representations, XA4C utilizes the SHapley Additive exPlanations (SHAP) framework. Specifically, it uses TreeSHAP with an XGBoost Regressor model. SHAP quantifies the contribution of each individual gene to each latent variable.
XA4C then defines a "Critical index" for each gene by averaging the absolute SHAP values across all latent variables and samples, weighted by the performance of the XGBoost model for each latent variable. Genes with the highest Critical indexes (top 1% by default) are identified as "Critical genes."
Datasets
The study primarily utilizes gene expression data from The Cancer Genome Atlas (TCGA) for six different cancer types:
- BRCA (Breast invasive carcinoma)
- COAD (Colon adenocarcinoma)
- KIRC (Kidney renal clear cell carcinoma)
- LUAD (Lung adenocarcinoma)
- PRAD (Prostate adenocarcinoma)
- THCA (Thyroid carcinoma)
The data was downloaded from the TCGA data portal and processed to retain genes with median expression levels higher than 1.0, resulting in approximately 15,000 genes per cancer type.
Key Insights and Ideas
- "Critical genes" offer a new perspective: XA4C introduces the concept of "Critical genes," which are distinct from traditional DiffEx and Hub genes. They represent genes that are crucial for understanding the complex, non-linear relationships captured by autoencoders.
- Beyond marginal effects and simple correlations: Critical genes capture more than just individual gene expression changes or pairwise correlations, suggesting they are involved in more intricate biological processes.
- High relevance to disease: Critical genes show a significantly higher enrichment in disease gene databases (like DisGeNET) compared to DiffEx or Hub genes, indicating their strong functional relevance to disease pathology.
- Novel biological insights: The low overlap between Critical genes and traditional gene sets suggests that XA4C uncovers novel biological information that was previously hidden.
- Dynamic interaction patterns: Critical genes can highlight distinct interaction patterns between tumor and normal tissues within specific pathways, offering a deeper understanding of disease mechanisms.
Key Results
- XA4C identifies novel genes: The study found that Critical genes have poor overlap with DiffEx and Hub genes across all six TCGA cancer types.
- Superior disease gene enrichment: Critical genes demonstrated significantly higher enrichment in the DisGeNET database compared to DiffEx and Hub genes, indicating their greater relevance to disease. This was quantified by a higher success rate in identifying validated genes.
- Pathway enrichment: XA4C identified pathways crucial in multiple cancers, including oxidative phosphorylation (OXPHOS) and glutathione metabolism.
- Distinct interaction patterns: In the Lysine degradation pathway, XA4C identified Critical genes that were neither Hub nor DiffEx genes. These Critical genes showed dramatically different co-expression patterns between tumor and normal tissues, as evidenced by Pearson correlation analysis and Kolmogorov-Smirnov tests.
- Performance comparison: XA4C outperformed other methods in terms of F1-score and accuracy when validated against DisGeNET, largely due to its superior precision.
Limitations and Future Work
- Fixed AE architectures: The study used fixed autoencoder architectures. The authors suggest that incorporating Bayesian Hyperparameter Optimization could lead to more extensive exploration of optimal architectures.
- Conventional AEs: Only conventional AEs were used. Future work could extend this to other AE variants like Variational AEs for causal inference or Graph AEs for learning causal structures.
- TreeSHAP efficiency: While effective, TreeSHAP can be less efficient for deep neural networks. The authors suggest exploring other SHAP explainers like DeepSHAP for potentially better performance.
- Sample-wise heterogeneity: The current Critical index is an average across all samples. Future work aims to uncover individualized Critical genes to support precision medicine by analyzing sample-specific heterogeneity.
- Transcriptome data only: XA4C currently supports only transcriptome data. A natural extension would be to incorporate other omics data, such as proteomics and metabolomics.
Summary updated